ArticleMolecular therapy. Nucleic acids2023

Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis.

Yoshikazu Kuboi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.